Rao Karan, Ahmed Mohammed, Brieger Daniel, Baer Alexandra, Hansen Peter, Bhindi Ravinay
Royal North Shore Hospital, Sydney, Australia.
North Shore Private Hospital, Sydney, Australia.
Struct Heart. 2024 Dec 26;9(3):100392. doi: 10.1016/j.shj.2024.100392. eCollection 2025 Mar.
Interference with the cardiac conduction system is common after transcatheter aortic valve implantation (TAVI), manifesting as atrioventricular block, or more commonly, new-onset persistent left bundle branch block (NOP-LBBB). Bundle branch block results in ventricular dyssynchrony and reduced cardiac output and may be associated with a poorer prognosis. This systematic review and meta-analysis evaluates the prognostic impact of a left or right bundle branch block after TAVI.
A systematic review was performed of the following online databases: PubMed, Medline, Scopus, and Web of Science, including English language studies from 2014 to 2024. Two separate searches for conducted for NOP-LBBB and new-onset persistent right bundle branch block (NOP-RBBB). The Newcastle-Ottawa Scale was used to evaluate risk of bias.
Twenty-three studies totaling 18875 patients were included for NOP-LBBB, whilst 5 studies with a total of 3525 patients were included for NOP-RBBB. NOP-LBBB was associated with higher all-cause mortality at 1 year (risk ratio [RR] 1.41 [95% CI 1.12-1.78], I = 49%, < 0.01), cardiovascular mortality (RR 1.34 [95% CI 1.02-1.75], I = 60%, = 0.02), heart failure-related rehospitalization (RR 1.56 [95% CI 1.31-1.84], I = 47%, < 0.01), and permanent pacemaker implantation at 1 year (RR 3.05 [95% CI 2.39-3.89], I = 14%, < 0.01). NOP-RBBB was not associated with higher all-cause mortality at 1 year (RR 1.74 [95% CI 0.88-3.46], I = 93%, = 0.11), however increased the risk of pacemaker implantation at 1 year (RR 4.68 [95% CI 3.60-6.08], I = 67%, < 0.01).
NOP-LBBB is associated with higher mortality and heart failure rehospitalization after TAVI, whilst both NOP-LBBB and NOP-RBBB increase the risk of permanent pacemaker implantation at 1 year after TAVI.
经导管主动脉瓣植入术(TAVI)后心脏传导系统受干扰很常见,表现为房室传导阻滞,或更常见的新发持续性左束支传导阻滞(NOP-LBBB)。束支传导阻滞会导致心室不同步和心输出量降低,可能与较差的预后相关。本系统评价和荟萃分析评估了TAVI后左束支或右束支传导阻滞的预后影响。
对以下在线数据库进行了系统评价:PubMed、Medline、Scopus和Web of Science,纳入2014年至2024年的英文研究。分别对NOP-LBBB和新发持续性右束支传导阻滞(NOP-RBBB)进行了两项独立检索。采用纽卡斯尔-渥太华量表评估偏倚风险。
纳入23项研究,共18875例患者用于NOP-LBBB分析,5项研究共3525例患者用于NOP-RBBB分析。NOP-LBBB与1年时全因死亡率较高相关(风险比[RR]1.41[95%CI 1.12-1.78],I² = 49%,P < 0.01)、心血管死亡率(RR 1.34[95%CI 1.02-1.75],I² = 60%,P = 0.02)、心力衰竭相关再住院率(RR 1.56[95%CI 1.31-1.84],I² = 47%,P < 0.01)以及1年时永久起搏器植入率(RR 3.05[95%CI 2.39-3.89],I² = 14%,P < 0.01)。NOP-RBBB与1年时全因死亡率较高无关(RR 1.74[95%CI 0.88-3.46],I² = 93%,P = 0.11),但增加了1年时起搏器植入风险(RR 4.68[95%CI 3.60-6.08],I² = 67%,P < 0.01)。
NOP-LBBB与TAVI后较高的死亡率和心力衰竭再住院率相关,而NOP-LBBB和NOP-RBBB均增加了TAVI后1年时永久起搏器植入的风险。